Skip to main content
. 2021 Jul 12;12:708019. doi: 10.3389/fphar.2021.708019

TABLE 3.

Biological analysis on day 5 in mitragynine replacement treatments.

Replacement groups Vehicle Mitragynine – Vehicle Mitragynine 1 mg/kg Methadone Mitragynine 0.8 mg/kg Buprenorphine Mitragynine 0.1 mg/kg Clonidine References range value
Total bilirubin (umol/L) 1.71 ± 0 2.28 ± 0.57 1.71 ± 0 2.28 ± 0.57 2.28 ± 0.57 0.0–5.1
Aspartate aminotransferase, AST (U/L) 117 ± 4.58 205.33 ± 36.08 169 ± 20.03 147 ± 1 220.33 ± 35.57 56.1–201.8
Alanine aminotransferase, ALT (U/L) 59 ± 6.11 74 ± 2.08 53 ± 2.31 58.33 ± 3.38 55.33 ± 6.69 34.9–218.1
Alkaline phosphatase (U/L) 299.67 ± 28.01 381.67 ± 119.7 337.33 ± 48.55 421 ± 86.97 253.33 ± 32.69 131.6–459.0
Sodium (mmol/L) 141.67 ± 1.45 139.33 ± 0.67 141 ± 1.73 143.67 ± 0.67 140.33 ± 0.88 121.9–162.6
Potassium (mmol/L) 6.7 ± 1.26 7.67 ± 0.12 7.8 ± 0.85 6.77 ± 0.24 7.1 ± 0.15 4.0–8.0
Chloride (mmol/L) 102.33 ± 0.88 102.33 ± 0.33 103 ± 0.58 104 ± 0 104.67 ± 1.2 81.5–104.0
Urea (mmol/L) 9.80 ± 0.3 8.33 ± 0.45 8.05 ± 0.11 14.45 ± 6.04 10.03 ± 0.45 4.32–34.4
Creatinine (umol/L) 49.87 ± 2.35 46.93 ± 0.59 46.35 ± 1.63 73.92 ± 33.93 43.71 ± 1.28 35.4–79.6
Total cholesterol (mmol/L) 1.70 ± 0.08 2.1 ± 0.11 1.59 ± 0.09# 1.47 ± 0.07# 1.74 ± 0.11 0.68–1.77
Triglycerides (mmol/L) 0.93 ± 0.19 0.82 ± 0.19 0.98 ± 0.09 0.99 ± 0.14 0.65 ± 0.15 0.23–0.99
Calcium (mmol/L) 2.41 ± 0.11 2.33 ± 0.11 2.48 ± 0.01 2.38 ± 0.03 2.28 ± 0.06 2.1–2.9
Phosphorus (mmol/L) 2 ± 0.30 2.36 ± 0.28 2.13 ± 0.25 2.22 ± 0.09 2.35 ± 0.17 1–3.94
Total protein (g/L) 70 ± 4.36 73.67 ± 1.76 65.67 ± 0.88 67.67 ± 1.86 69.67 ± 3.38 52–71
Albumin (g/L) 27 ± 2.08 28 ± 0.58 25.67 ± 0.88 26 ± 1.53 26.33 ± 1.33 26.85–34.55
Globulin (g/L) 43.33 ± 2.33 45.67 ± 2.19 40 ± 1.53 41.67 ± 1.2 43.33 ± 3.18 13–48
Albumin/Globulin ratio (g/L) 0.6 ± 0.06 0.63 ± 0.07 0.63 ± 0.03 0.63 ± 0.03 0.63 ± 0.07 0.6–1.21

Data represent means ± SEM of n = 6 rats/group *p < 0.05 vs. Vehicle, #p < 0.05 vs. Mitragynine-Vehicle, analysed by one-way repeated measures ANOVA and Bonferroni post-hoc test.